http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 06 Aug 2026 08:30:14 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Management+Changes/HCA+Healthcare+names+new+chief+clinical+officer+and+ambulatory+group+head/26879692.html <p>HCA Healthcare, Inc. (NYSE: HCA) announced two executive appointments, both effective Sept. 1, 2026, according to a company statement.</p> <p>Michael Schlosser, M.D., currently senior vice president and chief transformation officer, will become executive vice president and chief clinical officer. He succeeds Dr. Michael Cuffe, who announced in June his departure from the role effective Aug. 31. Dr. Cuffe will remain with the company as an executive consultant through February 2027.</p> <p>In his new role, Dr. Schlosser will report to chief executive officer Sam Hazen and will oversee the Clinical Services Group, which includes Quality, hospital Chief Medical Officers, Nursing, Graduate Medical Education, http://www.streetinsider.com/Management+Changes/HCA+Healthcare+names+new+chief+clinical+officer+and+ambulatory+group+head/26879692.html Thu, 06 Aug 2026 08:30:14 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Management+Changes/HCA+Healthcare+names+new+chief+clinical+officer+and+ambulatory+group+head/26879692.html <p>HCA Healthcare, Inc. (NYSE: HCA) announced two executive appointments, both effective Sept. 1, 2026, according to a company statement.</p> <p>Michael Schlosser, M.D., currently senior vice president and chief transformation officer, will become executive vice president and chief clinical officer. He succeeds Dr. Michael Cuffe, who announced in June his departure from the role effective Aug. 31. Dr. Cuffe will remain with the company as an executive consultant through February 2027.</p> <p>In his new role, Dr. Schlosser will report to chief executive officer Sam Hazen and will oversee the Clinical Services Group, which includes Quality, hospital Chief Medical Officers, Nursing, Graduate Medical Education, http://www.streetinsider.com/Management+Changes/HCA+Healthcare+names+new+chief+clinical+officer+and+ambulatory+group+head/26879692.html Thu, 06 Aug 2026 08:30:14 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Management+Changes/HCA+Healthcare+names+new+chief+clinical+officer+and+ambulatory+group+head/26879692.html <p>HCA Healthcare, Inc. (NYSE: HCA) announced two executive appointments, both effective Sept. 1, 2026, according to a company statement.</p> <p>Michael Schlosser, M.D., currently senior vice president and chief transformation officer, will become executive vice president and chief clinical officer. He succeeds Dr. Michael Cuffe, who announced in June his departure from the role effective Aug. 31. Dr. Cuffe will remain with the company as an executive consultant through February 2027.</p> <p>In his new role, Dr. Schlosser will report to chief executive officer Sam Hazen and will oversee the Clinical Services Group, which includes Quality, hospital Chief Medical Officers, Nursing, Graduate Medical Education, http://www.streetinsider.com/Management+Changes/HCA+Healthcare+names+new+chief+clinical+officer+and+ambulatory+group+head/26879692.html Thu, 06 Aug 2026 08:30:14 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Management+Changes/HCA+Healthcare+names+new+chief+clinical+officer+and+ambulatory+group+head/26879692.html <p>HCA Healthcare, Inc. (NYSE: HCA) announced two executive appointments, both effective Sept. 1, 2026, according to a company statement.</p> <p>Michael Schlosser, M.D., currently senior vice president and chief transformation officer, will become executive vice president and chief clinical officer. He succeeds Dr. Michael Cuffe, who announced in June his departure from the role effective Aug. 31. Dr. Cuffe will remain with the company as an executive consultant through February 2027.</p> <p>In his new role, Dr. Schlosser will report to chief executive officer Sam Hazen and will oversee the Clinical Services Group, which includes Quality, hospital Chief Medical Officers, Nursing, Graduate Medical Education, http://www.streetinsider.com/Management+Changes/HCA+Healthcare+names+new+chief+clinical+officer+and+ambulatory+group+head/26879692.html Thu, 06 Aug 2026 08:30:14 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Management+Changes/HCA+Healthcare+names+new+chief+clinical+officer+and+ambulatory+group+head/26879692.html <p>HCA Healthcare, Inc. (NYSE: HCA) announced two executive appointments, both effective Sept. 1, 2026, according to a company statement.</p> <p>Michael Schlosser, M.D., currently senior vice president and chief transformation officer, will become executive vice president and chief clinical officer. He succeeds Dr. Michael Cuffe, who announced in June his departure from the role effective Aug. 31. Dr. Cuffe will remain with the company as an executive consultant through February 2027.</p> <p>In his new role, Dr. Schlosser will report to chief executive officer Sam Hazen and will oversee the Clinical Services Group, which includes Quality, hospital Chief Medical Officers, Nursing, Graduate Medical Education, http://www.streetinsider.com/Management+Changes/HCA+Healthcare+names+new+chief+clinical+officer+and+ambulatory+group+head/26879692.html Thu, 06 Aug 2026 08:30:14 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Management+Changes/HCA+Healthcare+names+new+chief+clinical+officer+and+ambulatory+group+head/26879692.html <p>HCA Healthcare, Inc. (NYSE: HCA) announced two executive appointments, both effective Sept. 1, 2026, according to a company statement.</p> <p>Michael Schlosser, M.D., currently senior vice president and chief transformation officer, will become executive vice president and chief clinical officer. He succeeds Dr. Michael Cuffe, who announced in June his departure from the role effective Aug. 31. Dr. Cuffe will remain with the company as an executive consultant through February 2027.</p> <p>In his new role, Dr. Schlosser will report to chief executive officer Sam Hazen and will oversee the Clinical Services Group, which includes Quality, hospital Chief Medical Officers, Nursing, Graduate Medical Education, http://www.streetinsider.com/Management+Changes/HCA+Healthcare+names+new+chief+clinical+officer+and+ambulatory+group+head/26879692.html Thu, 06 Aug 2026 08:30:14 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Press+Releases/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html <p> NASHVILLE, Tenn.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhcahealthcare.com%2F&amp;esheet=54584737&amp;newsitemid=20260806085935&amp;lan=en-US&amp;anchor=HCA+Healthcare%2C+Inc.&amp;index=1&amp;md5=3d93e8edcf530fcb1e9b83ef94923502" shape="rect">HCA Healthcare, Inc.</a> (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. </p><p> Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. </p><p> Dr. Schlosser will succeed Dr. Michael Cuffe, who announced in June that he will step down as executive vice president and chief clinical officer, effective Aug. 31. </p><p> In his new role, Dr. Schlosser will report to Sam http://www.streetinsider.com/Press+Releases/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html Thu, 06 Aug 2026 08:30:00 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Press+Releases/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html <p> NASHVILLE, Tenn.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhcahealthcare.com%2F&amp;esheet=54584737&amp;newsitemid=20260806085935&amp;lan=en-US&amp;anchor=HCA+Healthcare%2C+Inc.&amp;index=1&amp;md5=3d93e8edcf530fcb1e9b83ef94923502" shape="rect">HCA Healthcare, Inc.</a> (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. </p><p> Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. </p><p> Dr. Schlosser will succeed Dr. Michael Cuffe, who announced in June that he will step down as executive vice president and chief clinical officer, effective Aug. 31. </p><p> In his new role, Dr. Schlosser will report to Sam http://www.streetinsider.com/Press+Releases/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html Thu, 06 Aug 2026 08:30:00 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Press+Releases/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html <p> NASHVILLE, Tenn.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhcahealthcare.com%2F&amp;esheet=54584737&amp;newsitemid=20260806085935&amp;lan=en-US&amp;anchor=HCA+Healthcare%2C+Inc.&amp;index=1&amp;md5=3d93e8edcf530fcb1e9b83ef94923502" shape="rect">HCA Healthcare, Inc.</a> (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. </p><p> Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. </p><p> Dr. Schlosser will succeed Dr. Michael Cuffe, who announced in June that he will step down as executive vice president and chief clinical officer, effective Aug. 31. </p><p> In his new role, Dr. Schlosser will report to Sam http://www.streetinsider.com/Press+Releases/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html Thu, 06 Aug 2026 08:30:00 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Press+Releases/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html <p> NASHVILLE, Tenn.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhcahealthcare.com%2F&amp;esheet=54584737&amp;newsitemid=20260806085935&amp;lan=en-US&amp;anchor=HCA+Healthcare%2C+Inc.&amp;index=1&amp;md5=3d93e8edcf530fcb1e9b83ef94923502" shape="rect">HCA Healthcare, Inc.</a> (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. </p><p> Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. </p><p> Dr. Schlosser will succeed Dr. Michael Cuffe, who announced in June that he will step down as executive vice president and chief clinical officer, effective Aug. 31. </p><p> In his new role, Dr. Schlosser will report to Sam http://www.streetinsider.com/Press+Releases/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html Thu, 06 Aug 2026 08:30:00 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Press+Releases/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html <p> NASHVILLE, Tenn.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhcahealthcare.com%2F&amp;esheet=54584737&amp;newsitemid=20260806085935&amp;lan=en-US&amp;anchor=HCA+Healthcare%2C+Inc.&amp;index=1&amp;md5=3d93e8edcf530fcb1e9b83ef94923502" shape="rect">HCA Healthcare, Inc.</a> (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. </p><p> Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. </p><p> Dr. Schlosser will succeed Dr. Michael Cuffe, who announced in June that he will step down as executive vice president and chief clinical officer, effective Aug. 31. </p><p> In his new role, Dr. Schlosser will report to Sam http://www.streetinsider.com/Press+Releases/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html Thu, 06 Aug 2026 08:30:00 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Press+Releases/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html <p> NASHVILLE, Tenn.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhcahealthcare.com%2F&amp;esheet=54584737&amp;newsitemid=20260806085935&amp;lan=en-US&amp;anchor=HCA+Healthcare%2C+Inc.&amp;index=1&amp;md5=3d93e8edcf530fcb1e9b83ef94923502" shape="rect">HCA Healthcare, Inc.</a> (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. </p><p> Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. </p><p> Dr. Schlosser will succeed Dr. Michael Cuffe, who announced in June that he will step down as executive vice president and chief clinical officer, effective Aug. 31. </p><p> In his new role, Dr. Schlosser will report to Sam http://www.streetinsider.com/Press+Releases/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html Thu, 06 Aug 2026 08:30:00 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Business+Wire/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html <p> NASHVILLE, Tenn.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhcahealthcare.com%2F&amp;esheet=54584737&amp;newsitemid=20260806085935&amp;lan=en-US&amp;anchor=HCA+Healthcare%2C+Inc.&amp;index=1&amp;md5=3d93e8edcf530fcb1e9b83ef94923502" shape="rect">HCA Healthcare, Inc.</a> (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. </p><p> Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. </p><p> Dr. Schlosser will succeed Dr. Michael Cuffe, who announced in June that he will step down as executive vice president and chief clinical officer, effective Aug. 31. </p><p> In his new role, Dr. Schlosser will report to Sam http://www.streetinsider.com/Business+Wire/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html Thu, 06 Aug 2026 08:30:00 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Business+Wire/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html <p> NASHVILLE, Tenn.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhcahealthcare.com%2F&amp;esheet=54584737&amp;newsitemid=20260806085935&amp;lan=en-US&amp;anchor=HCA+Healthcare%2C+Inc.&amp;index=1&amp;md5=3d93e8edcf530fcb1e9b83ef94923502" shape="rect">HCA Healthcare, Inc.</a> (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. </p><p> Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. </p><p> Dr. Schlosser will succeed Dr. Michael Cuffe, who announced in June that he will step down as executive vice president and chief clinical officer, effective Aug. 31. </p><p> In his new role, Dr. Schlosser will report to Sam http://www.streetinsider.com/Business+Wire/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html Thu, 06 Aug 2026 08:30:00 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Business+Wire/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html <p> NASHVILLE, Tenn.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhcahealthcare.com%2F&amp;esheet=54584737&amp;newsitemid=20260806085935&amp;lan=en-US&amp;anchor=HCA+Healthcare%2C+Inc.&amp;index=1&amp;md5=3d93e8edcf530fcb1e9b83ef94923502" shape="rect">HCA Healthcare, Inc.</a> (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. </p><p> Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. </p><p> Dr. Schlosser will succeed Dr. Michael Cuffe, who announced in June that he will step down as executive vice president and chief clinical officer, effective Aug. 31. </p><p> In his new role, Dr. Schlosser will report to Sam http://www.streetinsider.com/Business+Wire/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html Thu, 06 Aug 2026 08:30:00 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Business+Wire/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html <p> NASHVILLE, Tenn.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhcahealthcare.com%2F&amp;esheet=54584737&amp;newsitemid=20260806085935&amp;lan=en-US&amp;anchor=HCA+Healthcare%2C+Inc.&amp;index=1&amp;md5=3d93e8edcf530fcb1e9b83ef94923502" shape="rect">HCA Healthcare, Inc.</a> (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. </p><p> Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. </p><p> Dr. Schlosser will succeed Dr. Michael Cuffe, who announced in June that he will step down as executive vice president and chief clinical officer, effective Aug. 31. </p><p> In his new role, Dr. Schlosser will report to Sam http://www.streetinsider.com/Business+Wire/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html Thu, 06 Aug 2026 08:30:00 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Business+Wire/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html <p> NASHVILLE, Tenn.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhcahealthcare.com%2F&amp;esheet=54584737&amp;newsitemid=20260806085935&amp;lan=en-US&amp;anchor=HCA+Healthcare%2C+Inc.&amp;index=1&amp;md5=3d93e8edcf530fcb1e9b83ef94923502" shape="rect">HCA Healthcare, Inc.</a> (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. </p><p> Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. </p><p> Dr. Schlosser will succeed Dr. Michael Cuffe, who announced in June that he will step down as executive vice president and chief clinical officer, effective Aug. 31. </p><p> In his new role, Dr. Schlosser will report to Sam http://www.streetinsider.com/Business+Wire/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html Thu, 06 Aug 2026 08:30:00 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Business+Wire/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html <p> NASHVILLE, Tenn.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhcahealthcare.com%2F&amp;esheet=54584737&amp;newsitemid=20260806085935&amp;lan=en-US&amp;anchor=HCA+Healthcare%2C+Inc.&amp;index=1&amp;md5=3d93e8edcf530fcb1e9b83ef94923502" shape="rect">HCA Healthcare, Inc.</a> (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. </p><p> Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. </p><p> Dr. Schlosser will succeed Dr. Michael Cuffe, who announced in June that he will step down as executive vice president and chief clinical officer, effective Aug. 31. </p><p> In his new role, Dr. Schlosser will report to Sam http://www.streetinsider.com/Business+Wire/HCA+Healthcare+Announces+Dr.+Michael+Schlosser+as+Executive+Vice+President+and+Chief+Clinical+Officer%3B+Names+Charles+Gressle+President+of+New+Ambulatory+Operations+Group/26879669.html Thu, 06 Aug 2026 08:30:00 -0400 A.22325485 A.50204223 HCA O.00048708 O.00095911 O.50936667 http://www.streetinsider.com/Analyst+PT+Change/HCA+Healthcare+Inc+%28HCA%29+PT+Raised+to+%24381+at+Wells+Fargo/26853649.html Wells Fargo analyst Stephen Baxter raised the price target on HCA Healthcare Inc (NYSE: HCA) to $381.00 (from $369.00) while maintaining a Equal Weight rating. http://www.streetinsider.com/Analyst+PT+Change/HCA+Healthcare+Inc+%28HCA%29+PT+Raised+to+%24381+at+Wells+Fargo/26853649.html Mon, 03 Aug 2026 06:58:12 -0400 HCA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++HCA+Healthcare%2C+Inc.++++++For%3A+Jul+29/26835063.html si-local-file:///var/storage/secattach/20260729/26835063.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++HCA+Healthcare%2C+Inc.++++++For%3A+Jul+29/26835063.html Wed, 29 Jul 2026 16:10:00 -0400 HCA O.00095911 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++HCA+Healthcare%2C+Inc.++++++For%3A+Jul+29/26835063.html si-local-file:///var/storage/secattach/20260729/26835063.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++HCA+Healthcare%2C+Inc.++++++For%3A+Jul+29/26835063.html Wed, 29 Jul 2026 16:10:00 -0400 HCA O.00095911 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++HCA+Healthcare%2C+Inc.++++++For%3A+Jun+30/26827645.html si-local-file:///var/storage/secattach/20260728/26827645.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++HCA+Healthcare%2C+Inc.++++++For%3A+Jun+30/26827645.html Tue, 28 Jul 2026 16:31:00 -0400 HCA O.00095911 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++HCA+Healthcare%2C+Inc.++++++For%3A+Jun+30/26827645.html si-local-file:///var/storage/secattach/20260728/26827645.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++HCA+Healthcare%2C+Inc.++++++For%3A+Jun+30/26827645.html Tue, 28 Jul 2026 16:31:00 -0400 HCA O.00095911 http://www.streetinsider.com/Analyst+PT+Change/HCA+Healthcare+Inc+%28HCA%29+PT+Raised+to+%24426+at+Bernstein+SocGen+Group/26822479.html (Updated - July 28, 2026 9:26 AM EDT) <p>Bernstein SocGen Group analyst Lance Wilkes raised the price target on HCA Healthcare Inc (NYSE: HCA) to $426.00 (from $413.00) while maintaining a Market Perform rating.</p><p>The analyst commented: "Marketplace coverage reductions pressuring volumes; we lower LT EBITDA growth modestly; We maintain our Market-Perform rating and raise our price target to $426 as we roll forward our model. We modestly lower 2026 and beyond EBITDA forecasts and remain more moderate in EBITDA growth expectation with CAGR of 4.9% (2026-2030). Our take - We are cautious on hospital outlook as we see care delivery utilization http://www.streetinsider.com/Analyst+PT+Change/HCA+Healthcare+Inc+%28HCA%29+PT+Raised+to+%24426+at+Bernstein+SocGen+Group/26822479.html Tue, 28 Jul 2026 09:26:53 -0400 HCA http://www.streetinsider.com/Analyst+Comments/HCA+Healthcare+Inc+%28HCA%29+PT+Raised+to+%24426+at+Bernstein+SocGen+Group/26822479.html (Updated - July 28, 2026 9:26 AM EDT) <p>Bernstein SocGen Group analyst Lance Wilkes raised the price target on HCA Healthcare Inc (NYSE: HCA) to $426.00 (from $413.00) while maintaining a Market Perform rating.</p><p>The analyst commented: "Marketplace coverage reductions pressuring volumes; we lower LT EBITDA growth modestly; We maintain our Market-Perform rating and raise our price target to $426 as we roll forward our model. We modestly lower 2026 and beyond EBITDA forecasts and remain more moderate in EBITDA growth expectation with CAGR of 4.9% (2026-2030). Our take - We are cautious on hospital outlook as we see care delivery utilization http://www.streetinsider.com/Analyst+Comments/HCA+Healthcare+Inc+%28HCA%29+PT+Raised+to+%24426+at+Bernstein+SocGen+Group/26822479.html Tue, 28 Jul 2026 09:26:53 -0400 HCA